Glucophage (Metformin Hydrochloride)

Q: What is the mechanism of action of Glucophage (metformin hydrochloride)?

Glucophage reduces hepatic glucose production, decreases intestinal glucose absorption, and improves peripheral insulin sensitivity, helping to lower blood sugar levels.

Q: Can Glucophage be used in patients with mild kidney impairment?

Metformin is generally avoided in severe renal impairment, but may be used with dose adjustment and close monitoring in patients with mild to moderate reduction in kidney function.

Q: Is it safe to take Glucophage while pregnant?

The pregnancy safety category for metformin is listed as unknown; clinicians should weigh potential benefits against risks and consider alternative therapies when possible.

Q: How should Glucophage be taken to reduce gastrointestinal side effects?

Taking the medication with meals, starting at a low dose, and gradually titrating upward can help minimize nausea, diarrhea, and abdominal discomfort.

Q: What are the signs of lactic acidosis that require emergency care?

Symptoms include rapid breathing, muscle pain, abdominal discomfort, dizziness, and feeling unusually weak; these require immediate medical attention.

Q: Can Glucophage be combined with insulin therapy?

Yes, metformin is often used alongside insulin to improve overall glycemic control, but dose adjustments and monitoring are necessary.

Q: Does Glucophage cause weight loss?

Mild weight loss can occur as a result of reduced appetite and improved insulin sensitivity, but it is not a primary indication.

Q: What should I avoid while taking Glucophage before a radiologic procedure?

Iodinated contrast agents should be avoided or discontinued before imaging studies, as they can increase the risk of acute kidney injury when combined with metformin.

Q: Is Glucophage effective for treating polycystic ovary syndrome (PCOS)?

Metformin is sometimes used off‑label for PCOS to improve insulin resistance and menstrual regularity, though it is not formally approved for this indication.

Q: How often should liver function be monitored while on Glucophage?

Baseline liver enzymes should be checked before starting therapy, and periodic monitoring is recommended, especially if the patient has risk factors for hepatic disease.

Glucophage is the brand name for the oral medication metformin hydrochloride, a biguanide antidiabetic drug commonly supplied in tablet form. It is approved in the European Union for the management of elevated blood glucose in adults with type 2 diabetes mellitus. The product works by decreasing hepatic glucose production, reducing intestinal glucose absorption, and improving peripheral insulin sensitivity, thereby supporting glycemic control as part of a comprehensive treatment plan.

Manufacturer / TM Owner

Merck Serono Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glucophage is indicated for the treatment of type 2 diabetes mellitus and is used as part of a comprehensive glycemic management strategy.

Improves blood glucose control when used with diet and exercise in adults with type 2 diabetes.
Can be combined with other oral antidiabetic agents or insulin to achieve target HbA1c levels.
May be prescribed for patients with obesity‑related insulin resistance as an adjunct to lifestyle modification.
Used off‑label in some regions for polycystic ovary syndrome to improve metabolic parameters.
Recommended for long‑term maintenance therapy to prevent disease progression and complications.

Side Effects

Common and serious adverse reactions have been reported with metformin therapy; most are mild and reversible, while a few require immediate medical attention.

Common

Nausea, vomiting, or abdominal discomfort, especially during treatment initiation.
Diarrhea or loose stools that usually improve with dose adjustment.
Metallic taste in the mouth that may lessen over time.
Decreased appetite or mild weight loss.

Serious

Lactic acidosis, a rare but life‑threatening condition marked by rapid breathing and muscle pain.
Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

Before starting Glucophage, clinicians should evaluate patient history and laboratory values to minimize risks and ensure safe use.

Assess renal function; avoid use in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²).
Monitor liver enzymes; discontinue if hepatic disease is present or develops.
Check for contraindications such as acute or chronic metabolic acidosis.
Use caution in elderly patients due to higher risk of gastrointestinal side effects.
Advise patients to report unexplained fatigue, muscle pain, or rapid breathing promptly.

Avoid Interactions

Metformin may interact with several medications; some combinations should be avoided, while others require dose adjustments or close monitoring.

Avoid

Iodinated contrast agents used for imaging studies, which can precipitate acute kidney injury.
Cimetidine, as it may increase metformin plasma concentrations.
Certain antiretroviral drugs (e.g., didanosine) that raise the risk of lactic acidosis.

Use with caution

Diuretics and ACE inhibitors, which can affect renal function and metformin clearance.
Beta‑blockers, because they may mask hypoglycemia symptoms.
Thyroid hormones, as altered metabolism may influence glucose control.

Frequently Asked Questions